MedPath

A Pilot Randomized Control Trial to Help Youth Smokers to Quit Smoking:

Not Applicable
Conditions
Smoking Cessation
Interventions
Behavioral: Control group
Behavioral: Adventure-based intervention group
Behavioral: WhatsApp intervention group
Registration Number
NCT03021655
Lead Sponsor
The University of Hong Kong
Brief Summary

This study is a 3-arm randomized controlled trial including: (1) Adventure-based training intervention group, (2) WhatsApp intervention group and (3) Control group.

Detailed Description

Depression and stress are obstacles of youth smokers to quit smoking, youth smokers who have positive thinking and less depression exhibited smoking abstinence at last. Adventure-based training could enhance participants' self-efficacy, self-esteem and also improve mental health of children and youth by doing physical activity. On the other hand, previous mobile phone-based studies (e.g. short messaging services or Apps) showed that the mental health of youth had been improved by providing instant response to the subjects when they felt depressed. A paper published recently proved that WhatsApp group could prevent relapse among the quitters. Thus, adventure-based training and social support in WhatsApp group would predict to reduce depression and stress so as to quit smoking in youth.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
300
Inclusion Criteria
  • Hong Kong resident aged 25 or below
  • Able to communicate, read and write in Cantonese/ Chinese
  • Smoked in the past 30 days
  • Mobile can access internet
  • Would access internet through mobile or at home
Read More
Exclusion Criteria
  • Have difficulty to communicate via telephone
  • Ever used/using psychiatric drugs
  • Physically disabled
  • Having queries irrelevant to tobacco control
  • Undergoing other smoking cessation service
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Control groupControl groupFor the control group, the subjects will receive telephone counseling on quitting smoking at 1-week, 1-, 3-, 6-, 9-, 12- and 24-month.
Adventure-based intervention groupAdventure-based intervention groupAdventure-based intervention group included 1 day-camp and will be divided into 2 parts: (1) physical activity such as wall climbing, ropes course etc, (2) health education delivering about the relationship of self-efficacy, self-esteem, emotion and smoking abstinence. The training will be held before the 6-month follow-up. Telephone follow-up will be conducted at 1-week, 1-, 3-, 6-, 9-, 12- and 24-month.
WhatsApp intervention groupWhatsApp intervention groupFor WhatsApp intervention group, not more than 8 subjects with same gender will be assigned into a group. Messages about mood and stress management will be sent to the group per week and the group will last for 6 months. It aims to relieve their pressure and emotion by sharing their unhappy things with other subjects. Telephone follow-up will be conducted at 1-week, 1-, 3-, 6-, 9-, 12- and 24-month.
Primary Outcome Measures
NameTimeMethod
Self-reported 7-day point prevalence6-month

The subjects will be asked whether they have smoked cigarette in the past 7 day at 6-month

Secondary Outcome Measures
NameTimeMethod
Biochemical validated quit rate6-month

Bio-chemical validated quit rate will be conducted if the subjects who reported they have been stop smoking for at least 7 days at 6-month. They will be invited to perform saliva cotinine test (using NicAlert strip) plus exhaled carbon monoxide text to validate the smoking status.

Change in Self-esteem6-month

A 10-item scale (RSES) will be used to assess the self-esteem level of the subjects after 6 months.

Change in Depressive symptoms6-month

A 20-item scale (CESDC) will be used to assess the depressive symptoms of the subjects after 6 months.

Change in Quality of life6-month

A 11-item scale (SF-6D) will be used to assess the quality of life of the subjects after 6 months.

Trial Locations

Locations (1)

The University of Hong Kong

🇨🇳

Hong Kong, China

© Copyright 2025. All Rights Reserved by MedPath